论文部分内容阅读
我们自1978年12月至1980年10月,使用中国医科院药物研究所制全合成靛玉红(Indirubin)治疗慢性粒细胞性白血病(简称慢粒)22例,在临床上获得满意疗效。兹将有关资料分析报告如下。
From December 1978 to October 1980, 22 patients with chronic myelogenous leukemia (CML) were treated with Indirubin, a synthetic drug made by Institute of Materia Medica, Chinese Academy of Medical Sciences. We obtained satisfactory results clinically. The relevant information analysis report is as follows.